Document is current
Any future updates will be listed below
-
Authors
Eule, Corbin J. https://orcid.org/0000-0002-8430-1040
Flaig, Thomas W. https://orcid.org/0000-0001-6145-9040
Wong, Katy
Graf, Ryon https://orcid.org/0000-0002-8065-4148
Lam, Elaine T. https://orcid.org/0000-0001-5629-3402
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1UM1-CA186688-04, 1UM1-CA186688-04)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 7 August 2022
Revised: 18 October 2022
Accepted: 31 October 2022
First Online: 19 November 2022
Competing interests
: CJE has no conflicts of interest to disclose. TWF has received research funding from Roche/Genentech. KW and RG are employees of Foundation Medicine, a wholly owned subsidiary of Roche, and have equity interest in Roche. ETL has received institutional research funding from Roche/Genentech.
